Christoph Wanner

1 article listing Christoph Wanner in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension Nature Communications